StockData
Telix Pharmaceuticals Ltd logo

Telix Pharmaceuticals Ltd (TLX) stock

TLXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as TLPPF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 20, 2026Score 3/30
$8.96+0.11 (+1.19%)

Close on Nov 18, 2026Market cap $3.04BP/E –Yield –

Telix Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Telix Pharmaceuticals's market cap was $3.29B on Nov 11, 2026, against $3.43B a year earlier. Over the last 2 years it ranged from $2.50B to $6.02B, with a median of $3.71B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$3.29B+27.1%
2025Dec 31, 2025$2.59B-48.1%
2024Dec 31, 2024$4.99B–

More Telix Pharmaceuticals figures

See a number that looks wrong?